Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6191)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stein A, Bokemeyer C. How to select the optimal treatment for first line metastatic colorectal cancer. World J Gastroenterol 2014; 20(4): 899-907 [PMID: 24574764 DOI: 10.3748/wjg.v20.i4.899] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i4/899.htm |
| Number | Citing Articles |
| 1 |
Khaled M. Elamin, Yuki Yamashita, Keiichi Motoyama, Taishi Higashi, Hidetoshi Arima. Involvement of mitophagy-mediated cell death in colon cancer cells by folate-appended methyl-β-cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2017; 89(3-4): 333 doi: 10.1007/s10847-017-0757-x
|
| 2 |
Tianming Gao, Hua Tang, Baohuan Zhou, Dousheng Bai, Shengjie Jin, Chi Zhang, Guoqing Jiang. Can patients with gallbladder adenocarcinoma and liver metastases obtain survival benefit from surgery? A population-based study. Updates in Surgery 2022; 74(4): 1353 doi: 10.1007/s13304-022-01302-9
|
| 3 |
Donna A Messner. Evaluating the comparative effectiveness of treatment sequences in oncology: a new approach. Journal of Comparative Effectiveness Research 2015; 4(6): 537 doi: 10.2217/cer.15.47
|
| 4 |
Marilina García-Aranda, Maximino Redondo. Targeting Receptor Kinases in Colorectal Cancer. Cancers 2019; 11(4): 433 doi: 10.3390/cancers11040433
|
| 5 |
Ningning Dong, Fandong Meng, Yongdong Wu, Mingyu Wang, Yongchun Cui, Shutian Zhang. Genetic polymorphisms in cytochrome P450 and clinical outcomes of FOLFIRI chemotherapy in patients with metastatic colorectal cancer. Tumor Biology 2015; 36(10): 7691 doi: 10.1007/s13277-015-3492-1
|
| 6 |
Matti Korppi, Johanna Teräsjärvi, Milla Liehu-Martiskainen, Eero Lauhkonen, Juho Vuononvirta, Kirsi Nuolivirta, Liisa Kröger, Laura Pöyhönen, Minna K. Karjalainen, Qiushui He. Haplotype of the Interleukin 17A gene is associated with osteitis after Bacillus Calmette-Guerin vaccination. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12113-z
|
| 7 |
Long Bai, Feng Wang, Zhe-zhen Li, Chao Ren, Dong-sheng Zhang, Qi Zhao, Yun-xin Lu, De-shen Wang, Huai-qiang Ju, Miao-zhen Qiu, Zhi-qiang Wang, Feng-hua Wang, Rui-hua Xu. Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer. Medicine 2016; 95(51): e4531 doi: 10.1097/MD.0000000000004531
|
| 8 |
Sarah F�rster, Stephanie Hehlgans, Franz R�del, Benjamin Otto, Nils Cordes. Differential effects of α-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4279
|
| 9 |
Mohammed Dagher, Meritxell Sabidó, York Zöllner. Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies. Journal of Cancer Research and Clinical Oncology 2019; 145(8): 2105 doi: 10.1007/s00432-019-02948-6
|
| 10 |
Zhi-Bin Zhao, Jie Long, Yang-Yang Zhao, Jing-Bo Yang, Wei Jiang, Qing-Zhi Liu, Kai Yan, Liang Li, Yu-Cai Wang, Zhe-Xiong Lian. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles. Biomaterials Science 2018; 6(4): 893 doi: 10.1039/C8BM00106E
|
| 11 |
Yoshiaki Nakamura, Steven Olsen, Nicole Zhang, Jiemin Liao, Takayuki Yoshino. Comprehensive Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of a Real-World Healthcare Claims Database. Current Oncology 2022; 29(5): 3433 doi: 10.3390/curroncol29050277
|
| 12 |
Hong-hua Ding, Wei-dong Wu, Tao Jiang, Jun Cao, Zheng-yi Ji, Jia-hua Jin, Jing-jue Wang, Wei-feng Song, Li-wei Wang. Meta-analysis comparing the safety and efficacy of metastatic colorectal cancer treatment regimens, capecitabine plus irinotecan (CAPIRI) and 5-fluorouracil/leucovorin plus irinotecan (FOLFIRI). Tumor Biology 2015; 36(5): 3361 doi: 10.1007/s13277-014-2970-1
|
| 13 |
Mandy Poschau, Ellen Dickreuter, Jenny Singh-Müller, Katja Zscheppang, Iris Eke, Torsten Liersch, Nils Cordes. EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasion. Radiotherapy and Oncology 2015; 116(3): 510 doi: 10.1016/j.radonc.2015.06.005
|
| 14 |
Michael Tachezy, Florian Gebauer, Monika Janot, Waldemar Uhl, Alessandro Zerbi, Marco Montorsi, Julie Perinel, Mustapha Adham, Christos Dervenis, Christos Agalianos, Giuseppe Malleo, Laura Maggino, Alexander Stein, Jakob R. Izbicki, Maximilian Bockhorn. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery 2016; 160(1): 136 doi: 10.1016/j.surg.2016.02.019
|
| 15 |
Gulcan Bulut, Zehra Narli Ozdemir. Prognostic Significance of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer 2022; 53(1): 1 doi: 10.1007/s12029-021-00616-y
|
| 16 |
Elisabeth Mack, Kathleen Stabla, Jorge Riera-Knorrenschild, Roland Moll, Andreas Neubauer, Cornelia Brendel. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2589-2
|
| 17 |
Vladimir M. Moiseyenko, Fedor V. Moiseyenko, Grigoriy A. Yanus, Ekatherina Sh. Kuligina, Anna P. Sokolenko, Ilya V. Bizin, Alexey A. Kudriavtsev, Svetlana N. Aleksakhina, Nikita M. Volkov, Vyacheslav A. Chubenko, Kseniya S. Kozyreva, Mikhail M. Kramchaninov, Alexandr S. Zhuravlev, Kseniya V. Shelekhova, Denis V. Pashkov, Alexandr O. Ivantsov, Aigul R. Venina, Tatyana N. Sokolova, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina, Alexandr V. Togo, Aglaya G. Iyevleva, Evgeny N. Imyanitov. First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients. Clinical Drug Investigation 2018; 38(6): 553 doi: 10.1007/s40261-018-0629-1
|
| 18 |
Danysh Abetov, Zhanar Mustapova, Timur Saliev, Denis Bulanin, Kanat Batyrbekov, Charles P. Gilman. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways. Stem Cell Reviews and Reports 2015; 11(6): 909 doi: 10.1007/s12015-015-9612-x
|
| 19 |
Elena De Mattia, Jerry Polesel, Rossana Roncato, Adrien Labriet, Alessia Bignucolo, Eva Dreussi, Loredana Romanato, Michela Guardascione, Angela Buonadonna, Mario D'Andrea, Eric Lévesque, Derek Jonker, Félix Couture, Chantal Guillemette, Erika Cecchin, Giuseppe Toffoli. Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01312
|
| 20 |
Thierry André, Mark Saunders, Akira Kanehisa, Eric Gandossi, Ronan Fougeray, Nadia Causse Amellal, Alfredo Falcone. First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design. Future Oncology 2020; 16(4): 21 doi: 10.2217/fon-2019-0786
|
| 21 |
Harpreet S Wasan. Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases. Future Oncology 2014; 10(15s): 33 doi: 10.2217/fon.14.220
|
| 22 |
Nuria Garcia-Carbonero, Javier Martinez-Useros, Weiyao Li, Alberto Orta, Nuria Perez, Cristina Carames, Tatiana Hernandez, Irene Moreno, Gloria Serrano, Jesus Garcia-Foncillas. KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study. Cells 2020; 9(1): 219 doi: 10.3390/cells9010219
|